Stephen Fowler Flatt insider trades: National Healthcare (NHC) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Stephen reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | NHC | ↓ Sell | 1,500 | $237.08 | $356K | Direct | Aug 20, 2026 (1d) |
| Nov 21, 2025 | NHC | ↓ Sell | 1,000 | $130.33 | $130K | Direct | Nov 25, 2025 (4d) |
| Aug 14, 2024 | NHC | ↓ Sell | 3,907 | $126.54 | $494K | Direct | Aug 16, 2024 (2d) |
| Nov 12, 2015 | NHC | ↓ Sell | 1,000 | $65.55 | $66K | Direct | Nov 16, 2015 (4d) |
| Nov 10, 2015 | NHC | ↓ Sell | 2,300 | $66.20 | $152K | Direct | Nov 12, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NHC insiders
Open-market trades in the last 12 months
About Stephen Fowler Flatt's insider trades
Stephen Fowler Flatt is CEO at National Healthcare (NHC). Since Nov 10, 2015, Stephen has reported no open-market purchases and 5 sales worth $1.2M on SEC Form 4. In the last 12 months: 2 sales ($486K).
Their filings also include option exercises (22 filings), shares withheld for taxes (18 filings), grants and awards (15 filings), gifts (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NHC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.